Limited vitrectomy spares vitreous and reduces complications
Limited vitrectomy removes enough of the vitreous to relieve stress on macula


Roibeard O’hEineachain
Published: Tuesday, May 21, 2019
A novel limited vitrectomy surgical technique can be a safe and effective option to treat perifoveal pathologies while also reducing the rates of iatrogenic tears and cataract, said Robert McGrath MD, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.
“Whereas traditional vitrectomy involves removal of all of the vitreous gel, in limited vitrectomy the surgeon removes only enough of the vitreous to relieve the stress on the macula. It also leaves a tag of vitreous attached to the fovea and does not induce a posterior vitreous detachment (PVD),” Dr McGrath told the Annual Congress of the Irish College of Ophthalmologists in Galway, Ireland.
In 34 patients who underwent limited vitrectomy for vitreomacular traction (VMT), mean visual acuity (VA) improved from 0.32 logMAR preoperatively (range: 0.0-0.8) to 0.21 (range: 0.0-0.7) by two weeks postoperatively and to 0.16 (range 0.0-0.4) at a median follow-up of 13 months. Furthermore, there were no cases of iatrogenic progression of VMT to macular hole and no cases of retinal detachment.
In six patients who underwent the procedure for full-thickness-macular-hole, mean VA improved from 0.52 logMAR preoperatively to 0.5 at two weeks and 0.26 at last follow-up. One case was converted to full vitrectomy and required SF6 tamponade because the vitreous tuft became detached. In another case, the macular hole didn't close after the first surgery, but was successfully closed using an inverted inner limiting membrane flap technique.
Among two cases that underwent the procedure for sub-internal limiting membrane haemorrhage, the first case improved from 0.6 logMAR to 0.3 on day one and 0.1 by two weeks. The second case improved from 1.0 to 0.3 on day one and 0.0 by two weeks. Neither developed a PVD or cataract at last follow-up.
Tags: vitrectomy, vitreomacular traction
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.